Boston Scientific Latitude Connected (Concept) iPhone app
This week Boston Scientific announced that it had inked a deal with Vodafone Global Enterprise to develop mobile health monitoring devices that remotely provide physicians with real-time information about patients' cardiac health and other vital signs. The mobile health monitors will be cellular-enabled medical devices that patients use to send information to their care providers who will then be better positioned to respond to early signs of worsening patient conditions.
“With long patient lists and busy schedules, doctors are always looking for solutions that improve patient care while driving clinical efficiencies. Our collaboration with Vodafone allows us to use their mobile expertise and provide wireless remote patient monitoring services that appeal to both patients and healthcare providers," Boston Scientific Senior Vice President and President, Europe, Middle East and Africa, Michael Onuscheck, stated in the company announcement.
Given Onuscheck's title, it is likely the deal is for mobile health monitors set to launch in markets in EMEA. Last month Boston Scientific announced that it would leverage AT&T's cellular network to power the connectivity of future generations of its Latitude cardiac patient monitoring services, pending FDA clearances of the devices, of course. Those devices included future generations of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators and pacemakers (CRT-Ds and CRT-Ps), according to the companies.
For a few more details on the Vodafone deal with Boston Scientific, read the press release below:
PRESS RELEASE: Vodafone Global Enterprise – the business within Vodafone which manages the communications needs of its largest multinational customers – today announced an agreement with Boston Scientific Corporation, a global leader in the design of medical devices, to develop mobile health monitoring solutions that are set to transform healthcare by providing doctors with real-time information about patients' cardiac health and certain vital signs remotely.
Remote healthcare monitoring systems, powered by Vodafone's global world-leading* "machine-to-machine" (M2M) technology, will allow patients to use mobile devices to send health information to their doctor without having to leave their home. This reduces pressure on hospital outpatient and inpatient services and significantly increases the speed with which doctors and consultants can respond to early signs of deterioration in their patients' cardiac condition.
Vodafone Global Enterprise Chief Executive Nick Jeffery said: “The mobile internet has already transformed how people work, share their lives with friends and family and learn about the world around them. Wireless communications are now also set to change how we stay healthy and recover from illness. The new mobile technologies will empower both doctors and patients, enhancing quality of care while reducing costs and inefficiency."
Boston Scientific Senior Vice President and President, Europe, Middle East and Africa, Michael Onuscheck, said: “With long patient lists and busy schedules, doctors are always looking for solutions that improve patient care while driving clinical efficiencies. Our collaboration with Vodafone allows us to use their mobile expertise and provide wireless remote patient monitoring services that appeal to both patients and healthcare providers.”
For further information:
Vodafone Group
Media Relations
Telephone: +44 (0) 1635 664444
Boston Scientific
David Knutson
Media Relations
Telephone: 651-260-8288
Notes to Editors
About Vodafone Global Enterprise
Vodafone Global Enterprise provides managed communications services to many of the world’s leading global companies. It supports communications wherever its customers are present: in Europe, the Middle East, Africa, Asia Pacific and the United States. Vodafone was positioned in the "Leaders" quadrant of the Magic Quadrant for Pan-Western European Mobile Service Providers and the Magic Quadrant for Telecom Expense Management. Please visit: www.enterprise.vodafone.com
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com
About Vodafone machine-to-machine (M2M) communications
The Vodafone machine-to-machine (M2M) unit of Vodafone Global Enterprise connects previously isolated machines or devices wirelessly to the internet delivering new functionality and enhanced services without the need for human intervention. M2M technology makes common appliances more intelligent by enabling them to feed useful data back to the service provider or manufacturer to achieve a better customer experience. Supported by 20 years’ experience and 150 dedicated staff, Vodafone’s global M2M platform makes it easy for global businesses to centrally manage M2M deployments across multiple territories, with greater control and at a lower cost than previously possible. Vodafone’s M2M solutions operate principally in the utilities, automotive, logistics, and remote maintenance and security sectors. Please visit: http://m2m.vodafone.com/home/
*Vodafone is the world leader in providing machine-to-machine (M2M) wireless data services to global businesses, according to a recent Analysys Mason snapshot report which examined the performance of 12 communications providers worldwide. The report is based on the Analysys Mason M2M Communication Service Provider (“CSP”) Scorecard: 2011 which highlighted Vodafone’s focus on customer support, its delivery against Service Level Agreements and its ability to offer proven and trusted M2M solutions that are simple to integrate with customers' existing systems. The survey also emphasised Vodafone's broad network of partner suppliers - relationships which offer a crucial degree of flexibility when responding to customers' needs.
Vodafone is the CSP best positioned to take advantage of the global M2M market opportunity between now and 2020 according to the 2012 M2M Benchmarking study from Machina Research. In compiling the study Machina Research rated major M2M CSPs in six key areas that will determine their future success: Pedigree, Platform, Place, Partnerships, Process and People. Based on ratings across each of these six ‘P’s, Vodafone was the top-ranked CSP.
